Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call
08 8월 2023 - 8:30PM
Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced
that it will host a live conference call and webcast at 8:00 a.m.
ET on Tuesday, August 15, 2023 to report its second quarter
financial results and provide a corporate update.
Participants may access this event via the teleconferencing
numbers below and asking to join the Freeline call or through the
webcast link here.
- Domestic: 1-866-524-3160
- International: 1-412-317-6760
While not required, it is recommended that participants join the
call 10 minutes prior to the scheduled start. A live webcast of the
call will also be available on the Investors section of Freeline’s
website at www.freeline.life. An archived replay will be available
for approximately 90 days following the call.
About Freeline TherapeuticsFreeline is a
clinical-stage biotechnology company focused on developing
transformative gene therapies for chronic debilitating diseases.
Freeline uses its proprietary, rationally designed AAV vector and
capsid (AAVS3), along with novel promoters and transgenes, to
deliver a functional copy of a therapeutic gene into human liver
cells, thereby expressing a persistent functional level of the
missing or dysfunctional protein into a patient’s bloodstream. The
company is currently advancing FLT201, a highly differentiated gene
therapy candidate that delivers a novel transgene, in a Phase 1/2
clinical trial in people with Gaucher disease type 1. Freeline has
additional programs in research, including one focused on
GBA1-linked Parkinson’s disease that leverages the same novel
transgene as FLT201. Freeline is headquartered in the UK and has
operations in the United States. For more information,
visit www.freeline.life or connect with Freeline
on LinkedIn and Twitter.
Media and Investor Contact:Naomi
Aokinaomi.aoki@freeline.lifeSenior Vice President, Head of
Investor Relations & Communications+ 1 617 283 4298
Freeline Therapeutics (NASDAQ:FRLN)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Freeline Therapeutics (NASDAQ:FRLN)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024